Insight

Mar 8, 2024, 19:27

Fiza Khan: Our clinical quandary regarding the treatment of a BPDCN patient in a resource-limited setting published in Cancer Network

Fiza Khan, Assistant to Managing Editor at OncoDaily and Co-Founder and Vice President at YSMU Cardiology Society, shared a post on LinkedIn:

”Just in! With ongoing recent developments in treating BPDCN, I am excited to share our clinical quandary regarding the treatment of a BPDCN patient in a resource-limited setting published in Cancer Network.

Thanks to all my co authors: Gevorg Tamamyan, Elen Baloyan, Foorquan Hashmi, Naveen Pemmaraju, Nerses Ghahramanyan, Astghik Voskanyan.”

Read further
Source: Fiza Khan/LinkedIn

Astghik Voskanyan cancer Cancer Network Elen Baloyan Fiza Khan Foorquan Hashmi Gevorg Tamamyan Naveen Pemmaraju Nerses Ghahramanyan OncoDaily Oncology treating BPDCN

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage